|
Video: What is a Stock Split?
|
|
PainReform is a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics. Co.'s extended-release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. PRF-110, Co.'s first product candidate, is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. According to our PainReform stock split history records, PainReform has had 1 split. | |
|
PainReform (PRFX) has 1 split in our PainReform stock split history database. The split for PRFX took place on July 03, 2023. This was a 1 for 10 reverse split, meaning for each 10 shares of PRFX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as PainReform conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PainReform stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PainReform shares, starting with a $10,000 purchase of PRFX, presented on a split-history-adjusted basis factoring in the complete PainReform stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/02/2020 |
|
End date: |
05/06/2024 |
|
Start price/share: |
$65.00 |
|
End price/share: |
$0.84 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.71% |
|
Average Annual Total Return: |
-69.36% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$129.19 |
|
Years: |
3.68 |
|
|
|
Date |
Ratio |
07/03/2023 | 1 for 10 |
|
|